Myopia Control Effect of DIMS Spectacle Lenses in Czech Children and Young Adults
1 other identifier
observational
80
1 country
1
Brief Summary
The aim of this clinical study is to compare the efficacy of DIMS technology spectacle lenses with conventional single vision spectacle lenses at slowing the progression of myopia in the category of children and young adults during three years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 17, 2023
CompletedFirst Submitted
Initial submission to the registry
July 4, 2023
CompletedFirst Posted
Study publicly available on registry
July 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 12, 2026
April 2, 2024
March 1, 2024
3.5 years
July 4, 2023
March 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Axial length of eye
biometry (Lenstar 900)
in 36 moths therapy
Secondary Outcomes (1)
Objective refraction
in 36 month therapy
Study Arms (2)
Single Vision Spectacle Lens
Participants who chose to correct myopia with single vision spectacle lenses.
Defocus Incorporated Multiple Segments (DIMS) Spectacle Lens
Participants who chose to correct myopia with DIMS spectacle lenses.
Interventions
36 months of therapy
Eligibility Criteria
To evaluate the efficacy of Defocus Incorporated Multiple Segment (DIMS) lenses in slowing myopia progression in a young European population of progressing myopes. A prospective, non-randomized, observational 3 - year study will be conducted in 80 progressing myopes aged 6-26 years, with myopia between -0,25D and -8,5D and astigmatism -0,25 and -2,25DC. Participants self-selected wearing DIMS (n=55) or single vision (SV) lenses (n=25). Spherical Equivalent Refraction (SER, cycloplegic autorefraction) and axial length (AL) were measured at baseline. AL will be measured at 3M, 6M and every 6M and SER will be measured every 12M.
You may qualify if:
- Progressive myopia
- Myopes aged 6-26 years
- Myopia between -0,25D and -8,5D
- Astigmatism -0,25 and -2,25DC
You may not qualify if:
- Ocular pathology
- Amblyopia
- Strabism
- Non-compliance to eye examinations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Czech Technical University
Prague, Czech Republic, Czechia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Marketa Zakova, Ph.D.
Czech Technical University in Prague
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2023
First Posted
July 13, 2023
Study Start
April 17, 2023
Primary Completion (Estimated)
October 10, 2026
Study Completion (Estimated)
December 12, 2026
Last Updated
April 2, 2024
Record last verified: 2024-03